Keyphrases
Lung Transplantation
100%
Respiratory Syncytial Virus Bronchiolitis
92%
Azithromycin
92%
Recurrent Wheeze
74%
Cystic Fibrosis
67%
Wheezing
67%
Respiratory Syncytial Virus
67%
Clinical Trials
64%
Pediatric Lung Transplantation
61%
Design Characteristics
61%
Asthma
48%
St. Louis
41%
Children's Hospital
41%
Pediatric Patients
41%
Pediatric
39%
Airway Disorders
30%
Interstitial Lung Disease
30%
Bronchoscopy
30%
Hepatotoxicity
30%
Short-term Mortality
30%
In-training Examination
30%
Texting
30%
Short-term Morbidity
30%
Nine-level
30%
Matrix metalloproteinase-9 (MMP-9)
30%
Voriconazole
30%
Pediatric Residency
30%
Antifungal Prophylaxis
30%
Toddlers
30%
Micafungin
30%
American Thoracic Society
30%
Airway
30%
Pretransplant
30%
Mechanical Ventilation
30%
Upper Airway
22%
Amphotericin B
20%
Placebo
20%
Acute Rejection
18%
Older children
18%
Microbial Composition
17%
Transplant Center
15%
Hospital Discharge
15%
Question Answering
13%
3-year-olds
12%
Significant Risk Factors
11%
Day 14
11%
Continuing Medical Education
10%
Curriculum Update
10%
Nebulised Amphotericin B
10%
Ventilation
10%
Medicine and Dentistry
Azithromycin
92%
Human Respiratory Syncytial Virus
92%
Wheeze
92%
Bronchiolitis
92%
Pediatrics
92%
Lung Transplantation
84%
Clinical Trial
64%
Patient with Cystic Fibrosis
38%
Gelatinase B
30%
Interstitial Lung Disease
30%
Pediatrics Patient
30%
Artificial Respiration
30%
Lung
30%
Cystic Fibrosis
23%
Placebo
18%
Acute Graft Rejection
15%
Intensive Care
15%
Intensive Care Unit
15%
Asthma
11%
Prospective Study
10%
Adolescent Medicine
10%
Medicine
10%
Microbiome
8%
Quality of Life
7%
Patient Referral
7%
Immunosuppressive Treatment
7%
Continuing Medical Education
7%
Genetic Screening
7%
Lifespan
7%
Chronic Graft Rejection
7%
Graft Survival
7%
Cohort Analysis
7%
Bronchiolitis Obliterans
7%
Silo-Filler's Disease
7%
Clinician
7%
Body Growth
7%
Maintenance of Certification
7%
Survival Rate
7%
Diseases
7%
Graft Dysfunction
7%
Mortality Rate
7%
Body Mass Index
7%
Medical Record
7%
Living Donors
7%
Retrospective Cohort Study
7%
Pharmacology, Toxicology and Pharmaceutical Science
Human Respiratory Syncytial Virus
92%
Bronchiolitis
92%
Azithromycin
92%
Wheezing
92%
Clinical Trial
64%
Asthma
42%
Voriconazole
30%
Gelatinase B
30%
Hepatotoxicity
30%
Respiratory Tract Disease
30%
Cystic Fibrosis
30%
Micafungin
30%
Amphotericin
20%
Placebo
18%
Monotherapy
10%
Bilirubin
10%
Amphotericin B
10%
Microbiome
8%
Systemic Mycosis
5%
Hypertransaminasemia
5%
Bilirubin Glucuronide
5%
Prospective Study
5%
Aminotransferase
5%
Aspergillus
5%
Pyrrole
5%